The NPF has recently published a new strategy aiming to strengthen the collaboration between the Nordic countries. New, innovative and advanced therapies can offer hope and cure for patients, however it is an undisputed fact that there are multiple challenges related to their pricing. Quantify is especially keen to see the efforts of joint procurement and development of guidelines for joint price negotiations, and how these might increase the access of new drugs to patients in the Nordic markets! We are also excited about the renewed commitment for “green tenders”, and the continued effort to ensure environment sustainability as a procurement criterion. The new strategy also addresses how joint forces can help to secure supply and strengthen the Nordic voice.
If you wish to know more about the NPF’s new strategy, or learn more how we at Quantify can contribute to the access of new drugs on the market, don’t hesitate to contact us! Either reach out to Béranger Lueza, our Head of Modelling, Access and Strategy, here on LinkedIn, or send us an email at info@quantifyresearch.com.